Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites

Table 1

Characteristics of enrolled patients. Continuous variables are expressed as median (range). BMI: body mass index.

Gender (males), (%)	4 (40)
Age (years)	57.5 (45–68)
Etiology of liver disease, (%)
Alcoholic	3 (30)
HCV	2 (20)
HBV	1 (10)
Mixed	4 (40)
BMI	22.7 (19–33)
Serum bilirubin (mg/dl)	1.2 (0.6–3.5)
Serum creatinine (mg/dl)	1.2 (0.6–1.4)
Serum albumin (mg/dl)	34 (33–40)
Previous overt hepatic encephalopathy, (%)	8 (80%)
MELD score	11 (9–23)
MELD-Na score	16 (14–26)
Child-Pugh score classes, (%)
A	0
B	4 (40)
C	6 (60)
Propranolol titration dose (mg/day)	60 (40–120)
Diuretic therapy (mg/day)
Potassium canrenoate	200 (100–300)
Furosemide	50 (50–100)
Liters of ascites removed per procedure	7 (5–12)